351 related articles for article (PubMed ID: 29925896)
21. Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses.
Wang H; Zhou J; Wang D; Huang B; Tan W
Sci China Life Sci; 2020 Feb; 63(2):279-289. PubMed ID: 31147904
[TBL] [Abstract][Full Text] [Related]
22. Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.
Huang KA; Rijal P; Jiang H; Wang B; Schimanski L; Dong T; Liu YM; Chang P; Iqbal M; Wang MC; Chen Z; Song R; Huang CC; Yang JH; Qi J; Lin TY; Li A; Powell TJ; Jan JT; Ma C; Gao GF; Shi Y; Townsend AR
Nat Microbiol; 2019 Feb; 4(2):306-315. PubMed ID: 30478290
[TBL] [Abstract][Full Text] [Related]
23. Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head.
Jia M; Zhao H; Morano NC; Lu H; Lui YM; Du H; Becker JE; Yuen KY; Ho DD; Kwong PD; Shapiro L; To KK; Wu X
Nat Commun; 2024 May; 15(1):4505. PubMed ID: 38802413
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.
Meseda CA; Atukorale V; Soto J; Eichelberger MC; Gao J; Wang W; Weiss CD; Weir JP
Sci Rep; 2018 Mar; 8(1):5364. PubMed ID: 29599502
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
[TBL] [Abstract][Full Text] [Related]
27. An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.
Krammer F; Jul-Larsen A; Margine I; Hirsh A; Sjursen H; Zambon M; Cox RJ
Clin Vaccine Immunol; 2014 Aug; 21(8):1153-63. PubMed ID: 24943383
[TBL] [Abstract][Full Text] [Related]
28. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
[TBL] [Abstract][Full Text] [Related]
29. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
[TBL] [Abstract][Full Text] [Related]
30. Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice.
Wang Y; Zhang Y; Wu J; Lin Y; Wu Z; Wei Y; Wei X; Qin J; Xue C; Liu GD; Cao Y
Virus Res; 2017 Oct; 242():16-23. PubMed ID: 28912070
[TBL] [Abstract][Full Text] [Related]
31. In silico structural homology modelling and docking for assessment of pandemic potential of a novel H7N9 influenza virus and its ability to be neutralized by existing anti-hemagglutinin antibodies.
Rajapaksha H; Petrovsky N
PLoS One; 2014; 9(7):e102618. PubMed ID: 25047593
[TBL] [Abstract][Full Text] [Related]
32. One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.
Klausberger M; Wilde M; Palmberger D; Hai R; Albrecht RA; Margine I; Hirsh A; García-Sastre A; Grabherr R; Krammer F
Vaccine; 2014 Jan; 32(3):355-62. PubMed ID: 24262313
[TBL] [Abstract][Full Text] [Related]
33. Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin.
Goff PH; Krammer F; Hai R; Seibert CW; Margine I; García-Sastre A; Palese P
J Virol; 2013 Jul; 87(14):8235-40. PubMed ID: 23698299
[TBL] [Abstract][Full Text] [Related]
34. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses.
Jiang WM; Wang SC; Liu HL; Yu JM; Du X; Hou GY; Li JP; Liu S; Wang KC; Zhuang QY; Liu XM; Chen JM
Vaccine; 2014 Nov; 32(48):6433-9. PubMed ID: 25285880
[TBL] [Abstract][Full Text] [Related]
36.
Sutton TC; Lamirande EW; Bock KW; Moore IN; Koudstaal W; Rehman M; Weverling GJ; Goudsmit J; Subbarao K
J Virol; 2017 Dec; 91(24):. PubMed ID: 29046448
[TBL] [Abstract][Full Text] [Related]
37. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.
Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980
[TBL] [Abstract][Full Text] [Related]
39. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
[TBL] [Abstract][Full Text] [Related]
40. Emergence and Adaptation of a Novel Highly Pathogenic H7N9 Influenza Virus in Birds and Humans from a 2013 Human-Infecting Low-Pathogenic Ancestor.
Qi W; Jia W; Liu D; Li J; Bi Y; Xie S; Li B; Hu T; Du Y; Xing L; Zhang J; Zhang F; Wei X; Eden JS; Li H; Tian H; Li W; Su G; Lao G; Xu C; Xu B; Liu W; Zhang G; Ren T; Holmes EC; Cui J; Shi W; Gao GF; Liao M
J Virol; 2018 Jan; 92(2):. PubMed ID: 29070694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
